Xeltis is a European medical device company dedicated to developing care in heart valve replacement and vascular surgery. Its restorative heart valves enable the patient’s own body to naturally form a new heart valve through a therapeutic approach called Endogenous Tissue Restoration.

Employee Rating

4.0More
TypePrivate
HQZürich, CH
Size (employees)59 (est)+2%
Websitexeltis.com
Xeltis is headquartered in Zürich, CH
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Xeltis

Laurent Grandidier

Laurent Grandidier

Chief Executive Officer and Board Member
Martin de Groot

Martin de Groot

CFO
Boris Warnack

Boris Warnack

COO
Martijn Cox

Martijn Cox

Chief Technology Officer and Co-Founder
Oleg Svanidze

Oleg Svanidze

Chief Medical Officer
Stefan K. Widensohler

Stefan K. Widensohler

Chairman of the Board
Show more

Xeltis Office Locations

Xeltis has offices in Zürich and Eindhoven
Zürich, (HQ)
35 Seefeldstrasse
Eindhoven,
31 De Lismortel
Show all (2)
Report incorrect company information

Xeltis Financials and Metrics

Summary Metrics

Xeltis total Funding

$119.5 m

Xeltis latest funding size

$53.03 m

Time since last funding

a year ago

Xeltis investors

Xeltis's latest funding round in November 2017 was reported to be $53 m. In total, Xeltis has raised $119.5 m
Show all financial metrics
Report incorrect company information

Xeltis Online and Social Media Presence

Embed Graph
Report incorrect company information

Xeltis Blogs

Xeltis data shortlisted at EACTS Techno-College Innovation Award

An abstract on Xeltis clinical data has been shortlisted as one of five finalists at the EACTS Techno-College Innovation Awards. Professor Tomasz Mroczek from the Children’s University Hospital, Krakow, Poland will present 1-year Xeltis data on the “First clinical experience with restorative pulmona…

Xeltis’ New Chairman and Board Member

Xeltis has welcomed Stefan K. Widensohler as the new Chairman of the Board, following his nomination by Xeltis Board members. Stefan has over 25 years of experience as a healthcare entrepreneur and has been an active investor and board member of several companies in the industry, including the Board…

Xeltis’ aortic valve one of highest peer-review oral abstracts at TCT

Initial in vivo experience on Xeltis’ restorative aortic valve will feature as one of the highest peer-reviewed oral abstracts of TCT 2018. Professor Christian Spaulding, Chief, Interventional Cardiology, European Hospital Georges Pompidou, Paris (F), will present long-term preclinical on Xeltis’ ao…

Xeltis’ restorative technology featured at ISACB

Preclinical data on Xeltis’ restorative heart valve technology will feature at the 16th International Society of Applied Cardiovascular Biology (ISACB) Biennial meeting. Professor Frederick J. Schoen from Harvard Medical School will present 1-year preclinical data outlining the capability of Xeltis …

Xplore-2 trial information for clinicians online

U.S. clinicians can now learn more about the FDA-approved Xplore-2 clinical trial online. The trial is currently recruiting pediatric patients across several leading centers in the USA. Xplore-2 is an FDA-approved Early Feasibility Study evaluating Xeltis’ novel restorative pulmonary heart valve for…

Cincinnati Children’s Hospital joins the Xplore-2 trial

Cincinnati Children’s Hospital has joined other prominent U.S. pediatric centers in the Xplore-2 FDA-approved clinical research study, the first medical center in the Midwest to take part in the trial. The medical institutions already enrolling patients as part of the Xplore-2 trial include: Boston …
Show more

Xeltis Company Life and Culture

Report incorrect company information

Xeltis Frequently Asked Questions

  • Who are Xeltis key executives?

    Xeltis's key executives are Laurent Grandidier, Martin de Groot and Boris Warnack.

  • How many employees does Xeltis have?

    Xeltis has 59 employees.

  • Who are Xeltis competitors?

    Competitors of Xeltis include VertiFlex, REVA Medical and Arthrex.

  • Where is Xeltis headquarters?

    Xeltis headquarters is located at 35 Seefeldstrasse, Zürich.

  • Where are Xeltis offices?

    Xeltis has offices in Zürich and Eindhoven.

  • How many offices does Xeltis have?

    Xeltis has 2 offices.